Birchview Capital, LP Diversified Active

Location: Burlington, VT

CIK: 0001618205 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 9, 2021

Total Value: $174M (100.0% shares, 0.0% debt)

Holdings (48)

BMY BRISTOL-MYERS SQUIBB CO 28.4%
Value $49.28M Shares 794,386 Share Price $62.03 * Est. Cost/Share $44.70 Unrealized @ Report Date +11.9%
— BIODESIX INC 12.8%
Value $22.28M Shares 1,105,083 Share Price $20.16 Est. Cost/Share $20.16 Unrealized @ Report Date —
— ACCELERATE DIAGNOSTICS INC 9.6%
Value $16.63M Shares 2,193,795 Share Price $7.58 Est. Cost/Share $19.28 Unrealized @ Report Date —
— QUIDEL CORP 6.1%
Value $10.54M Shares 58,644 Share Price $179.64 Est. Cost/Share $66.26 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 4.4%
Value $7.687M Shares 80,200 Share Price $95.85 Est. Cost/Share $70.20 Unrealized @ Report Date +37.6%
FHTX FOGHORN THERAPEUTICS INC 3.7%
Value $6.368M Shares 314,143 Share Price $20.27 * Est. Cost/Share $19.16 Unrealized @ Report Date 0.0%
— ASPIRA WOMENS HEALTH INC 3.2%
Value $5.62M Shares 840,104 Share Price $6.69 Est. Cost/Share $3.84 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 3.1%
Value $5.453M Shares 102,000 Share Price $53.46 * Est. Cost/Share $39.48 Unrealized @ Report Date +25.7%
— ALBIREO PHARMA INC 2.0%
Value $3.451M Shares 92,000 Share Price $37.51 Est. Cost/Share $34.15 Unrealized @ Report Date —
— OXFORD IMMUNOTEC GLOBAL PLC 1.7%
Value $2.974M Shares 170,303 Share Price $17.46 Est. Cost/Share $13.84 Unrealized @ Report Date —
BIIB BIOGEN INC 1.7%
Value $2.963M Shares 12,100 Share Price $244.88 * Est. Cost/Share $287.32 Unrealized @ Report Date -9.8%
— KARYOPHARM THERAPEUTICS INC 1.7%
Value $2.91M Shares 188,000 Share Price $15.48 Est. Cost/Share $17.15 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 1.6%
Value $2.732M Shares 18,000 Share Price $151.78 * Est. Cost/Share $93.09 Unrealized @ Report Date +41.0%
— BLUEBIRD BIO INC 1.5%
Value $2.683M Shares 62,000 Share Price $43.27 Est. Cost/Share $60.46 Unrealized @ Report Date —
— ACCELERON PHARMA INC 1.4%
Value $2.389M Shares 18,672 Share Price $127.95 Est. Cost/Share $36.87 Unrealized @ Report Date —
MASI MASIMO CORP 1.2%
Value $2.147M Shares 8,000 Share Price $268.38 * Est. Cost/Share $24.68 Unrealized @ Report Date +910.5%
— CHEMOCENTRYX INC 1.1%
Value $1.858M Shares 30,000 Share Price $61.93 Est. Cost/Share $39.66 Unrealized @ Report Date —
— ARENA PHARMACEUTICALS INC 1.0%
Value $1.69M Shares 22,000 Share Price $76.82 Est. Cost/Share $41.96 Unrealized @ Report Date —
— SOLENO THERAPEUTICS INC 0.9%
Value $1.596M Shares 826,899 Share Price $1.93 Est. Cost/Share $2.23 Unrealized @ Report Date —
— AMARIN CORP PLC 0.8%
Value $1.467M Shares 300,000 Share Price $4.89 Est. Cost/Share $7.50 Unrealized @ Report Date —
— PROGENITY INC 0.8%
Value $1.328M Shares 250,000 Share Price $5.31 Est. Cost/Share $5.31 Unrealized @ Report Date —
CORT CORCEPT THERAPEUTICS INC 0.8%
Value $1.308M Shares 50,000 Share Price $26.16 * Est. Cost/Share $6.85 Unrealized @ Report Date +207.4%
ARVN ARVINAS INC 0.7%
Value $1.274M Shares 15,000 Share Price $84.93 * Est. Cost/Share $16.46 Unrealized @ Report Date +109.5%
STOK STOKE THERAPEUTICS INC 0.7%
Value $1.239M Shares 20,000 Share Price $61.95 * Est. Cost/Share $24.71 Unrealized @ Report Date +85.5%
HROW HARROW HEALTH INC 0.7%
Value $1.235M Shares 180,000 Share Price $6.86 * Est. Cost/Share $6.05 Unrealized @ Report Date -6.7%
— IMMUNOGEN INC 0.7%
Value $1.226M Shares 190,000 Share Price $6.45 Est. Cost/Share $2.74 Unrealized @ Report Date —
— EQUITRANS MIDSTREAM CORPORATIO 0.6%
Value $1.07M Shares 133,050 Share Price $8.04 Est. Cost/Share $8.31 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 0.6%
Value $1.051M Shares 80,000 Share Price $13.14 * Est. Cost/Share $14.87 Unrealized @ Report Date -19.0%
— CONTRAFECT CORP 0.6%
Value $1.01M Shares 200,000 Share Price $5.05 Est. Cost/Share $0.81 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 0.5%
Value $877K Shares 38,000 Share Price $23.08 * Est. Cost/Share $14.56 Unrealized @ Report Date +40.4%
— BIOHAVEN PHARMACEUTICAL HOLDING CO LTD 0.5%
Value $857K Shares 10,000 Share Price $85.70 Est. Cost/Share $54.40 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.4%
Value $780K Shares 15,000 Share Price $52.00 * Est. Cost/Share $13.75 Unrealized @ Report Date +145.7%
— BMY CVR RTS 03/31/21 0.4%
Value $763K Shares 1,105,313 Share Price $0.69 Est. Cost/Share $2.70 Unrealized @ Report Date —
— G1 THERAPEUTICS INC 0.4%
Value $720K Shares 40,000 Share Price $18.00 Est. Cost/Share $33.05 Unrealized @ Report Date —
PGNY PROGYNY INC 0.4%
Value $636K Shares 15,000 Share Price $42.40 * Est. Cost/Share $23.98 Unrealized @ Report Date +35.7%
— CONTINENTAL RESOURCES INC 0.4%
Value $629K Shares 38,600 Share Price $16.30 Est. Cost/Share $17.54 Unrealized @ Report Date —
— INARI MEDICAL INC 0.4%
Value $611K Shares 7,000 Share Price $87.29 Est. Cost/Share $48.40 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 0.3%
Value $570K Shares 30,000 Share Price $19.00 * Est. Cost/Share $16.16 Unrealized @ Report Date +6.1%
— TRANSLATE BIO INC 0.3%
Value $553K Shares 30,000 Share Price $18.43 Est. Cost/Share $9.97 Unrealized @ Report Date —
XNCR XENCOR INC 0.3%
Value $537K Shares 12,300 Share Price $43.66 * Est. Cost/Share $15.78 Unrealized @ Report Date +162.0%
OVV OVINTIV INC 0.3%
Value $493K Shares 34,350 Share Price $14.35 * Est. Cost/Share $6.97 Unrealized @ Report Date +68.0%
APLS APELLIS PHARMACEUTICALS INC 0.3%
Value $458K Shares 8,000 Share Price $57.25 * Est. Cost/Share $27.68 Unrealized @ Report Date +52.8%
— PIONEER NATURAL RESOURCES CO 0.2%
Value $433K Shares 3,800 Share Price $113.95 Est. Cost/Share $145.33 Unrealized @ Report Date —
— ODONATE THERAPEUTICS INC 0.2%
Value $384K Shares 20,000 Share Price $19.20 Est. Cost/Share $19.40 Unrealized @ Report Date —
IFRX INFLARX NV 0.2%
Value $352K Shares 70,000 Share Price $5.03 * Est. Cost/Share $3.70 Unrealized @ Report Date +21.5%
— DICERNA PHARMACEUTICALS INC 0.1%
Value $220K Shares 10,000 Share Price $22.00 Est. Cost/Share $4.60 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 0.1%
Value $149K Shares 20,000 Share Price $7.45 * Est. Cost/Share $6.02 Unrealized @ Report Date -14.3%
— YIELD10 BIOSCIENCE INC 0.1%
Value $110K Shares 18,952 Share Price $5.80 Est. Cost/Share $0.24 Unrealized @ Report Date —